Duality Advisers LP acquired a new position in shares of Danaher Co. (NYSE:DHR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,886 shares of the conglomerate’s stock, valued at approximately $2,455,000.

Several other hedge funds also recently bought and sold shares of the company. Everett Harris & Co. CA lifted its stake in shares of Danaher by 2.6% in the second quarter. Everett Harris & Co. CA now owns 12,256 shares of the conglomerate’s stock worth $2,167,000 after acquiring an additional 316 shares in the last quarter. Tompkins Financial Corp increased its holdings in shares of Danaher by 1.4% during the second quarter. Tompkins Financial Corp now owns 25,327 shares of the conglomerate’s stock worth $4,478,000 after buying an additional 354 shares in the last quarter. Stelac Advisory Services LLC bought a new position in Danaher in the 2nd quarter valued at $127,000. Iberiabank Corp boosted its stake in Danaher by 34.8% in the second quarter. Iberiabank Corp now owns 26,013 shares of the conglomerate’s stock worth $4,600,000 after purchasing an additional 6,710 shares in the last quarter. Finally, Main Street Research LLC grew its holdings in shares of Danaher by 7.8% during the second quarter. Main Street Research LLC now owns 96,608 shares of the conglomerate’s stock worth $17,083,000 after purchasing an additional 6,951 shares during the last quarter. Institutional investors own 77.67% of the company’s stock.

Shares of DHR opened at $203.80 on Friday. The stock has a 50 day simple moving average of $182.24 and a 200 day simple moving average of $161.95. Danaher Co. has a 52-week low of $119.60 and a 52-week high of $204.13. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.74 and a current ratio of 2.20. The firm has a market capitalization of $142.15 billion, a PE ratio of 43.64, a P/E/G ratio of 3.20 and a beta of 0.92.

Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, July 23rd. The conglomerate reported $1.44 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.09 by $0.35. Danaher had a net margin of 17.73% and a return on equity of 11.88%. The company had revenue of $5.30 billion during the quarter, compared to analysts’ expectations of $5.01 billion. During the same quarter in the prior year, the company earned $1.09 earnings per share. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. Equities research analysts predict that Danaher Co. will post 5.42 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Friday, June 26th were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.35%. The ex-dividend date was Thursday, June 25th. Danaher’s dividend payout ratio is 16.29%.

Several research firms have weighed in on DHR. Robert W. Baird raised their price objective on shares of Danaher from $163.00 to $205.00 and gave the company an “outperform” rating in a research report on Friday, July 24th. Stifel Nicolaus upped their price objective on Danaher from $170.00 to $210.00 and gave the stock a “hold” rating in a report on Friday, July 24th. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 target price for the company in a research report on Tuesday, June 16th. Bank of America lifted their price objective on Danaher from $181.00 to $215.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Finally, Citigroup upped their target price on shares of Danaher from $180.00 to $190.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $197.73.

In other Danaher news, CFO Matthew Mcgrew sold 7,457 shares of the business’s stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $203.42, for a total transaction of $1,516,902.94. Following the sale, the chief financial officer now directly owns 12,387 shares of the company’s stock, valued at approximately $2,519,763.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Daniel L. Comas sold 100,032 shares of the firm’s stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $194.56, for a total value of $19,462,225.92. Following the completion of the transaction, the executive vice president now owns 134,933 shares of the company’s stock, valued at approximately $26,252,564.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 498,929 shares of company stock worth $94,446,919. Corporate insiders own 11.70% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Recommended Story: Learning About the VIX – Volatility Index

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.